Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R)

Melrilimab (anti-IL-1RL1/ ST2 / IL-33R) is an anti-ST2 (IL-1RL) monoclonal antibody targeting the IL-33 receptor. Melrilimab has the potential to be used in asthma research. MW: 145.2 KD.

• Supplier: Selleck Chemicals
• Product #: A2962
• Sku #: A2962-1mg*25